These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9496148)

  • 1. Urokinase in rheumatoid arthritis: causal or coincidental?
    Busso N; So A
    Ann Rheum Dis; 1997 Dec; 56(12):705-6. PubMed ID: 9496148
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen activators and their inhibitors in arthritic disease.
    Hamilton JA; Campbell IK; Wojta J; Cheung D
    Ann N Y Acad Sci; 1992 Dec; 667():87-100. PubMed ID: 1309075
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.
    Busso N; Péclat V; So A; Sappino AP
    Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells.
    Guiducci S; Del Rosso A; Cinelli M; Margheri F; D'Alessio S; Fibbi G; Matucci Cerinic M; Del Rosso M
    Clin Exp Rheumatol; 2005; 23(3):364-72. PubMed ID: 15971425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.
    Werb Z; Mainardi CL; Vater CA; Harris ED
    N Engl J Med; 1977 May; 296(18):1017-23. PubMed ID: 66627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.
    Verheijen JH; Nieuwenbroek NM; Beekman B; Hanemaaijer R; Verspaget HW; Ronday HK; Bakker AH
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):603-9. PubMed ID: 9169591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
    Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
    Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
    Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
    Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlation with the PA/plasmin system in septic arthritis of the knee.
    Hsieh YS; Yang SF; Lue KH; Lu KH
    Clin Orthop Relat Res; 2006 Jun; 447():172-8. PubMed ID: 16505706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary urokinase-converting protease and its comparison with plasmin.
    Hayashi S; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):995-8. PubMed ID: 2945353
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme secretion in the pathogenesis of rheumatoid arthritis.
    Lancet; 1977 Jun; 1(8023):1190-1. PubMed ID: 68283
    [No Abstract]   [Full Text] [Related]  

  • 14. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
    Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
    Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease activity in synovial tissue extracts.
    Andersen RB; Gormsen J; Petersen PH
    Scand J Rheumatol; 1972; 1(2):75-9. PubMed ID: 4266939
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophilins in rheumatoid arthritis--stepping into an undiscovered country?
    Pap T
    Clin Immunol; 2005 Sep; 116(3):199-201. PubMed ID: 16039162
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Nakano S; Ikata T; Kinoshita I; Kanematsu J; Yasuoka S
    Clin Exp Rheumatol; 1999; 17(2):161-70. PubMed ID: 10342041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
    van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
    Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.